HomeCompareNBSD vs JNJ

NBSD vs JNJ: Dividend Comparison 2026

NBSD yields 4.90% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NBSD wins by $7.6K in total portfolio value
10 years
NBSD
NBSD
● Live price
4.90%
Share price
$50.71
Annual div
$2.49
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.6K
Annual income
$670.53
Full NBSD calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NBSD vs JNJ

📍 NBSD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNBSDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NBSD + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NBSD pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBSD
Annual income on $10K today (after 15% tax)
$416.54/yr
After 10yr DRIP, annual income (after tax)
$569.95/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $133.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBSD + JNJ for your $10,000?

NBSD: 50%JNJ: 50%
100% JNJ50/50100% NBSD
Portfolio after 10yr
$23.8K
Annual income
$749.16/yr
Blended yield
3.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NBSD
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBSD buys
0
JNJ buys
0
No recent congressional trades found for NBSD or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNBSDJNJ
Forward yield4.90%3.36%
Annual dividend / share$2.49$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$27.6K$20.0K
Annual income after 10y$670.53$827.78
Total dividends collected$5.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NBSD vs JNJ ($10,000, DRIP)

YearNBSD PortfolioNBSD Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,190$490.04$10,676$355.77+$514.00NBSD
2$12,486$512.48$11,407$389.39+$1.1KNBSD
3$13,894$534.42$12,198$426.53+$1.7KNBSD
4$15,423$555.80$13,056$467.62+$2.4KNBSD
5$17,079$576.58$13,987$513.12+$3.1KNBSD
6$18,871$596.72$14,998$563.56+$3.9KNBSD
7$20,808$616.21$16,098$619.52+$4.7KNBSD
8$22,900$635.01$17,295$681.69+$5.6KNBSD
9$25,156$653.12$18,599$750.82+$6.6KNBSD
10$27,587$670.53$20,022$827.78+$7.6KNBSD

NBSD vs JNJ: Complete Analysis 2026

NBSDStock

Multi-sector fixed income portfolio focused on the front-end of the curve

Full NBSD Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NBSD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBSD vs SCHDNBSD vs JEPINBSD vs ONBSD vs KONBSD vs MAINNBSD vs ABBVNBSD vs MRKNBSD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.